About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [211 citations: 101–200 of 210 articles]

Articles published in Chemotherapy Research and Practice have been cited 211 times. The following is a list of the 210 articles that have cited the articles published in Chemotherapy Research and Practice.

  • Gyoergy Varady, Judit Cserepes, Adrienn Nemeth, Edit Szabo, and Balazs Sarkadi, “Cell surface membrane proteins as personalized biomarkers: where we stand and where we are headed,” Biomarkers in Medicine, vol. 7, no. 5, pp. 803–819, 2013. View at Publisher · View at Google Scholar
  • Dionysis Papadatos-Pastos, Aspasia Soultati, and Mark Harries, “Targeting Brain Metastases in Patients with Melanoma,” BioMed Research International, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • Dan Cao, Ye Chen, Yuan Tang, Xing-Chen Peng, Hang Dong, Long-Hao Li, Ke Cheng, Jun Ge, and Ji-Yan Liu, “Loss of RASSF1A Expression in Colorectal Cancer and Its Association with K-ras Status,” BioMed Research International, vol. 2013, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • Kari-Elise T. Codispoti, Stacy Mosier, Robert Ramsey, Ming-Tseh Lin, and Fausto J. Rodriguez, “Genetic and pathologic evolution of early secondary gliosarcoma,” Brain Tumor Pathology, 2013. View at Publisher · View at Google Scholar
  • Cynthia X. Ma, Vera J. Suman, Matthew Goetz, Paul Haluska, Timothy Moynihan, Rita Nanda, Olufunmilayo Olopade, Timothy Pluard, Zhanfang Guo, Helen X. Chen, Charles Erlichman, Matthew J. Ellis, and Gini F. Fleming, “A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer,” Breast Cancer Research And Treatment, vol. 139, no. 1, pp. 145–153, 2013. View at Publisher · View at Google Scholar
  • Ingar Seemann, Johannes A. M. te Poele, Ji-Ying Song, Saske Hoving, Nicola S. Russell, and Fiona A. Stewart, “Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents,” Breast Cancer Research and Treatment, vol. 141, no. 3, pp. 385–395, 2013. View at Publisher · View at Google Scholar
  • S. Kamiura, M. Fujita, K. Matsuo, S. Mabuchi, M. Okazawa, Y. Matsumoto, T. Tsutsui, T. Kimura, K. Ogawa, and C. P. Morrow, “Utility of risk-weighted surgical-pathological factors in early-stage cervical cancer,” British Journal Of Cancer, vol. 108, no. 6, pp. 1348–1357, 2013. View at Publisher · View at Google Scholar
  • D. Gonzalez, L. Fearfield, P. Nathan, P. Taniere, A. Wallace, E. Brown, C. Harwood, J. Marsden, and S. Whittaker, “BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel,” British Journal Of Dermatology, vol. 168, no. 4, pp. 700–707, 2013. View at Publisher · View at Google Scholar
  • Junya Zhu, Dhruv B. Sharma, Aileen B. Chen, Bruce E. Johnson, Jane C. Weeks, and Deborah Schrag, “Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced nonsmall cell lung cancer,” Cancer, vol. 119, no. 11, pp. 2048–2060, 2013. View at Publisher · View at Google Scholar
  • Lixia Ju, and Caicun Zhou, “Integrin beta 1 enhances the epithelial-mesenchymal transition in association with gefitinib resistance of non-small cell lung cancer,” Cancer Biomarkers, vol. 13, no. 5, pp. 329–336, 2013. View at Publisher · View at Google Scholar
  • Iris Eke, Katja Storch, Mechthild Krause, and Nils Cordes, “Cetuximab Attenuates Its Cytotoxic and Radiosensitizing Potential by Inducing Fibronectin Biosynthesis,” Cancer Research, vol. 73, no. 19, pp. 5869–5879, 2013. View at Publisher · View at Google Scholar
  • Hong Zhou, Lawrence H. Cheung, Walter N. Hittelman, Hideo Yagita, Jeffrey A. Winkles, Michael G. Rosenblum, and Stuart S. Martin, “Antitumor Activity of a Humanized, Bivalent Immunotoxin Targeting Fn14-Positive Solid Tumors,” Cancer Research, vol. 73, no. 14, pp. 4439–4450, 2013. View at Publisher · View at Google Scholar
  • D. C. Coraca-Huber, J. Hausdorfer, M. Fille, M. Steidl, and M. Nogler, “Effect of two cleaning processes for bone allografts on gentamicin impregnation and in vitro antibiotic release,” Cell And Tissue Banking, vol. 14, no. 2, pp. 221–229, 2013. View at Publisher · View at Google Scholar
  • Valeria Maria Piccolini, Maria Grazia Bottone, Giovanni Bottiroli, Sandra Angelica De Pascali, Francesco Paolo Fanizzi, and Graziella Bernocchi, “Platinum drugs and neurotoxicity: effects on intracellular calcium homeostasis,” Cell Biology and Toxicology, vol. 29, no. 5, pp. 339–353, 2013. View at Publisher · View at Google Scholar
  • Samarth Hegde, and Srikala Raghavan, “A Skin-depth Analysis of Integrins: Role of the Integrin Network in Health and Disease,” Cell Communication and Adhesion, vol. 20, no. 6, pp. 155–169, 2013. View at Publisher · View at Google Scholar
  • Bruna Corominas-Faja, Cristina Oliveras-Ferraros, Elisabet Cuyas, Antonio Segura-Carretero, Jorge Joven, Begona Martin-Castillo, Enrique Barrajon-Catalan, Vicente Micol, Joaquim Bosch-Barrera, and Javier A. Menendez, “Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin,” Cell Cycle, vol. 12, no. 21, pp. 3390–3404, 2013. View at Publisher · View at Google Scholar
  • C. R. I. Lam, C. Tan, Z. Teo, C. Y. Tay, T. Phua, Y. L. Wu, P. Q. Cai, L. P. Tan, X. Chen, P. Zhu, and N. S. Tan, “Loss of TAK1 increases cell traction force in a ROS-dependent manner to drive epithelial-mesenchymal transition of cancer cells,” Cell Death & Disease, vol. 4, 2013. View at Publisher · View at Google Scholar
  • S Wansleben, E Davis, J Peres, and S Prince, “A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance,” Cell Death and Disease, vol. 4, no. 10, pp. e846, 2013. View at Publisher · View at Google Scholar
  • Fereshteh Mir Mohammadrezaei, Homa Mohseni Kouchesfehani, Hamed Montazeri, Mehdi Gharghabi, Seyed Nasser Ostad, and Mohammad Hossein Ghahremani, “Signaling crosstalk of FHIT, CHK2 and p38 in etoposide induced growth inhibition in MCF-7 cells,” Cellular Signalling, vol. 25, no. 1, pp. 126–132, 2013. View at Publisher · View at Google Scholar
  • Dana S. Neel, and Trever G. Bivona, “Secrets of Drug Resistance in NSCLC Exposed by New Molecular Definition of EMT,” Clinical Cancer Research, vol. 19, no. 1, pp. 3–5, 2013. View at Publisher · View at Google Scholar
  • Alixis Van Horn, and Cynthia Harrison, “Neurologic Complications of Cancer and Cancer Therapy,” Clinical Journal Of Oncology Nursing, vol. 17, no. 4, pp. 418–424, 2013. View at Publisher · View at Google Scholar
  • Tony K. L. Kiang, Kyle J. Wilby, and Mary H. H. Ensom, “Clinical Pharmacokinetic Drug Interactions Associated with Artemisinin Derivatives and HIV-Antivirals,” Clinical Pharmacokinetics, 2013. View at Publisher · View at Google Scholar
  • Vladimir P. Chekhonin, Anna A. Korchagina, Sergey A. Shein, and Olga I. Gurina, “VEGF in Tumor Progression and Targeted Therapy,” Current Cancer Drug Targets, vol. 13, no. 4, pp. 423–443, 2013. View at Publisher · View at Google Scholar
  • G. Cheve, C. Bories, M. Coisy-Quivy, R. Benhida, A. Yasri, B. Fauvel, and P. Warnault, “Recent Advances in Drug Design of Epidermal Growth Factor Receptor Inhibitors,” Current Medicinal Chemistry, vol. 20, no. 16, pp. 2043–2067, 2013. View at Publisher · View at Google Scholar
  • Manuel Diezi, Thierry Buclin, and Thierry Kuntzer, “Toxic and drug-induced peripheral neuropathies: updates on causes, mechanisms and management,” Current Opinion in Neurology, vol. 26, no. 5, pp. 481–488, 2013. View at Publisher · View at Google Scholar
  • Nicolas Authier, Vanessa Pereira, Jeremy Ferrier, and Jerome Busserolles, “Emerging Trends in Understanding Chemotherapy-Induced Peripheral Neuropathy,” Current Pain And Headache Reports, vol. 17, no. 10, 2013. View at Publisher · View at Google Scholar
  • Devron R. Shah, Rashmi R. Shah, and Joel Morganroth, “Tyrosine Kinase Inhibitors: Their On-Target Toxicities as Potential Indicators of Efficacy,” Drug Safety, vol. 36, no. 6, pp. 413–426, 2013. View at Publisher · View at Google Scholar
  • Andrew D. Norden, Eudocia Q. Lee, Rameen Beroukhim, Lakshmi Nayak, Patrick Y. Wen, and Mikael L. Rinne, “Update on bevacizumab and other angiogenesis inhibitors for brain cancer,” Expert Opinion On Emerging Drugs, vol. 18, no. 2, pp. 137–153, 2013. View at Publisher · View at Google Scholar
  • Hebatallah Hassan, Burkhard Greve, Mauro S. G. Pavao, Ludwig Kiesel, Sherif A. Ibrahim, and Martin Goette, “Syndecan-1 modulates beta-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation,” Febs Journal, vol. 280, no. 10, pp. 2216–2227, 2013. View at Publisher · View at Google Scholar
  • Jodee L. Johnson, and Elvira Gonzalez de Mejia, “Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro,” Food and Chemical Toxicology, 2013. View at Publisher · View at Google Scholar
  • Mohammad Waseem, and Suhel Parvez, “Mitochondrial dysfunction mediated cisplatin induced toxicity: Modulatory role of curcumin,” Food And Chemical Toxicology, vol. 53, pp. 334–342, 2013. View at Publisher · View at Google Scholar
  • Miguel Gueimonde, Borja Sanchez, Clara G. de los Reyes-Gavilan, and Abelardo Margolles, “Miguel Gueimonde, Borja Sonchez, Clara G. de los Reyes-Gavilan and Abelardo Margolies,” Frontiers in Microbiology, vol. 4, 2013. View at Publisher · View at Google Scholar
  • Satu Maki-Nevala, Virinder Kaur Sarhadi, Katja Tuononen, Sonja Lagstrom, Pekka Ellonen, Mikko Ronty, Aino Wirtanen, Aija Knuuttila, and Sakari Knuutila, “Mutated Ephrin Receptor Genes in Non-Small Cell Lung Carcinoma and Their Occurrence with Driver Mutations-Targeted Resequencing Study on Formalin-Fixed, Paraffin-Embedded Tumor Material of 81 Patients,” Genes Chromosomes & Cancer, vol. 52, no. 12, pp. 1141–1149, 2013. View at Publisher · View at Google Scholar
  • T. N. Kakuda, R. DeMasi, Y. van Delft, and P. Mohammed, “Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial,” Hiv Medicine, vol. 14, no. 7, pp. 421–429, 2013. View at Publisher · View at Google Scholar
  • Ke Li, Ling Tian, Yanli Luo, Qian Huang, Min Wang, Chuanyuan Li, and Ling Zhou, “Molecular markers of therapeutic resistance in breast cancer,” Human Pathology, vol. 44, no. 7, pp. 1421–1428, 2013. View at Publisher · View at Google Scholar
  • Monika E. Freiser, Paolo Serafini, and Donald T. Weed, “The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities,” Immunologic Research, 2013. View at Publisher · View at Google Scholar
  • Mika Okazawa, Seiji Mabuchi, Fumiaki Isohashi, Osamu Suzuki, Yasuo Yoshioka, Tomoyuki Sasano, Yukinobu Ohta, Shoji Kamiura, Kazuhiko Ogawa, and Tadashi Kimura, “Impact of the Addition of Concurrent Chemotherapy to Pelvic Radiotherapy in Surgically Treated Stage IB1-IIB Cervical Cancer Patients With Intermediate-Risk or High-Risk Factors A 13-Year Experience,” International Journal Of Gynecological Cancer, vol. 23, no. 3, pp. 567–575, 2013. View at Publisher · View at Google Scholar
  • Alberto Antonicelli, Stefano Cafarotti, Alice Indini, Alessio Galli, Andrea Russo, Alfredo Cesario, Filippo Maria Lococo, Patrizia Russo, Alberto Franco Mainini, Luca Giuseppe Bonifati, Mario Nosotti, Luigi Santambrogio, Stefano Margaritora, Pierluigi Maria Granone, and Andre Emanuel Dutly, “EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation,” International Journal Of Medical Sciences, vol. 10, no. 3, pp. 320–330, 2013. View at Publisher · View at Google Scholar
  • Rafael Paletta-Silva, Nathália Rocco-Machado, and José Meyer-Fernandes, “NADPH Oxidase Biology and the Regulation of Tyrosine Kinase Receptor Signaling and Cancer Drug Cytotoxicity,” International Journal of Molecular Sciences, vol. 14, no. 2, pp. 3683–3704, 2013. View at Publisher · View at Google Scholar
  • Demin Liu, Chunbai He, Andrew Z. Wang, and Wenbin Lin, “Application of liposomal technologies for delivery of platinum analogs in oncology,” International Journal Of Nanomedicine, vol. 8, pp. 3309–3319, 2013. View at Publisher · View at Google Scholar
  • S. E. Salem, E. Dahdouh, and Z. Daoud, “Resistance of Gram-Negative Bacilli in Lebanon,” ISRN Infectious Diseases, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • V. Patil, V. Noronha, A. Joshi, Vamshi Muddu Krishna, S. Juvekar, Gauri Pantvaidya, Pankaj Chaturvedi, D. Chaukar, Supreeta Arya, Aswari Patil, B. Bhosale, A. Dongre, A. K. Dcruz, and K. Prabhash, “Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?,” ISRN Oncology, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • Kentaro Tamaki, Nobumitsu Tamaki, Yoshihiko Kamada, Kano Uehara, Hisamitsu Zaha, Mai Onomura, Masanori Gushimiyagi, Kaname Kurashita, Keiko Miyazato, Hiromu Tengan, Kyuichiro Miyara, and Takanori Ishida, “The Challenge to Reduce Breast Cancer Mortality in Okinawa: Consensus of the First Okinawa Breast Oncology Meeting,” Japanese Journal Of Clinical Oncology, vol. 43, no. 2, pp. 208–213, 2013. View at Publisher · View at Google Scholar
  • Stanley R. Hamilton, “BRAF Mutation and Microsatellite Instability Status in Colonic and Rectal Carcinoma: Context Really Does Matter,” Jnci-Journal Of The National Cancer Institute, vol. 105, no. 15, pp. 1075–1077, 2013. View at Publisher · View at Google Scholar
  • Jose Manuel Lerma-Diaz, Pablo Cesar Ortiz-Lazareno, Luis F. Jave-Suarez, Ruth De Celis-Carrillo, Adriana Aguilar-Lemarroy, Alejandro Bravo-Cuellar, Georgina Hernandez-Flores, Jorge Ramiro Dominguez-Rodriguez, and Paulina Gomez-Lomeli, “Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl-XL and phosphorylation of p65,” Journal Of Biomedical Science, vol. 20, 2013. View at Publisher · View at Google Scholar
  • Behnamfar Fariba, Nadereh Behtash, Fatemeh Gaemmaghami, Elahe Rezayof, Mitra M. Gillani, and Azam Sadat Moosavi, “The WHO score predicts treatment outcome in low risk gestational trophoblastic neoplasia patients treated with weekly intramuscular methotrexate,” Journal Of Cancer Research And Therapeutics, vol. 9, no. 1, pp. 38–43, 2013. View at Publisher · View at Google Scholar
  • Hong-Quan Duong, Young Bin Hong, Jung Soon Kim, Hee-Seok Lee, Yong Weon Yi, Yeon Jeong Kim, Antai Wang, Wenjing Zhao, Chi Heum Cho, Yeon-Sun Seong, and Insoo Bae, “Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine,” Journal of Cellular and Molecular Medicine, vol. 17, no. 10, pp. 1261–1270, 2013. View at Publisher · View at Google Scholar
  • Hsin-Ling Yang, Kai-Yuan Lin, Ying-Chen Juan, K.J. Senthil Kumar, Tzong-Der Way, Pei-Chun Shen, Ssu-Ching Chen, and You-Cheng Hseu, “The anti-cancer activity of Antrodia camphorata against human ovarian carcinoma (SKOV-3) cells via modulation of HER-2/neu signaling pathway,” Journal of Ethnopharmacology, vol. 148, no. 1, pp. 254–265, 2013. View at Publisher · View at Google Scholar
  • Marina Elli, Stefania Arioli, Simone Guglielmetti, and Diego Mora, “Biocide susceptibility in bifidobacteria of human origin,” Journal of Global Antimicrobial Resistance, 2013. View at Publisher · View at Google Scholar
  • Tiangui Huang, Michael Karsy, Jian Zhuge, Minghao Zhong, and Delong Liu, “B-Raf and the inhibitors: from bench to bedside,” Journal of Hematology & Oncology, vol. 6, 2013. View at Publisher · View at Google Scholar
  • Julius Steffen, and Jan Steffen, “Driving Forces Behind the Past and Future Emergence of Personalized Medicine,” Journal of Personalized Medicine, vol. 3, no. 1, pp. 14–22, 2013. View at Publisher · View at Google Scholar
  • Shashi Rajput, B. N. Prashanth Kumar, Kaushik Kumar Dey, Ipsita Pal, Aditya Parekh, and Mahitosh Mandal, “Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells,” Life Sciences, vol. 93, no. 21, pp. 783–790, 2013. View at Publisher · View at Google Scholar
  • Larissa A. Pikor, Varune R. Ramnarine, Stephen Lam, and Wan L. Lam, “Genetic alterations defining NSCLC subtypes and their therapeutic implications,” Lung Cancer, vol. 82, no. 2, pp. 179–189, 2013. View at Publisher · View at Google Scholar
  • Suzanne E. Dahlberg, Tien Hoang, David H. Johnson, and Joan H. Schiller, “Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594,” Lung Cancer, vol. 81, no. 1, pp. 47–52, 2013. View at Publisher · View at Google Scholar
  • Chi-Chao Liu, Pascal Leclair, Shyong Quin Yap, and Chinten James Lim, “The Membrane-Proximal KXGFFKR Motif of alpha-Integrin Mediates Chemoresistance,” Molecular and Cellular Biology, vol. 33, no. 21, pp. 4334–4345, 2013. View at Publisher · View at Google Scholar
  • Marcus Vinicius Ortega Alves, Alison L. Fitzgerald, Jeffrey N. Myers, Mayur A. Gadhikar, Mitchell J. Frederick, Maria Rita Sciuto, Abdullah A. Osman, Curtis R. Pickering, David M. Neskey, and Mei Zhao, “Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional p53,” Molecular Cancer Therapeutics, vol. 12, no. 9, pp. 1860–1873, 2013. View at Publisher · View at Google Scholar
  • Anjali Singh, Xueqing Lun, Aarthi Jayanthan, Halah Obaid, Yibing Ruan, Douglas Strother, Susan N. Chi, Amy Smith, Peter Forsyth, and Aru Narendran, “Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR- ErbB2 signaling with lapatinib,” Molecular Oncology, vol. 7, no. 3, pp. 497–512, 2013. View at Publisher · View at Google Scholar
  • Natalia V. Nukolova, Hardeep S. Oberoi, Yi Zhao, Vladimir P. Chekhonin, and Tatiana K. Bronich, “LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer,” Molecular Pharmaceutics, vol. 10, no. 10, pp. 3913–3921, 2013. View at Publisher · View at Google Scholar
  • Pranali P Deshpande, Swati Biswas, and Vladimir P Torchilin, “Current trends in the use of liposomes for tumor targeting,” Nanomedicine, vol. 8, no. 9, pp. 1509–1528, 2013. View at Publisher · View at Google Scholar
  • Yong Wang, Baoyan Liu, Dezhi Xu, Haitao Zhao, Yufang Zhu, Jun Xu, and Rongjie Tao, “Phase II trial of temozolomide plus concurrent whole-brain radiation followed by TNV regimen as adjuvant therapy for patients with newly diagnosed primary CNS lymphoma,” Neurology India, vol. 61, no. 3, pp. 260–264, 2013. View at Publisher · View at Google Scholar
  • Giada Santin, Valeria M. Piccolini, Sergio Barni, Paola Veneroni, Vincenzo Giansanti, Veronica Dal Bo, Graziella Bernocchi, and Maria Grazia Bottone, “Mitochondrial fusion: A mechanism of cisplatin-induced resistance in neuroblastoma cells?,” NeuroToxicology, vol. 34, pp. 51–60, 2013. View at Publisher · View at Google Scholar
  • Jianwei Ge, Yongming Qiu, Qing Mao, Pin Guo, and Jin Lan, “ID1 regulates U87 human cell proliferation and invasion,” Oncology Letters, vol. 6, no. 4, pp. 921–926, 2013. View at Publisher · View at Google Scholar
  • Abiodun Falodun, Nadja Engel, Udo Kragl, Barbara Nebe, and Peter Langer, “Novel anticancer alkene lactone from Persea americana,” Pharmaceutical Biology, vol. 51, no. 6, pp. 700–706, 2013. View at Publisher · View at Google Scholar
  • Hisataka Sabe, Yasuhito Onodera, and Jin-Min Nam, “Intracellular trafficking of integrins in cancer cells,” Pharmacology & Therapeutics, vol. 140, no. 1, pp. 1–9, 2013. View at Publisher · View at Google Scholar
  • Atul A. Bharde, Raghavendra Palankar, Cornelia Fritsch, Arjen Klaver, Johannes S. Kanger, Thomas M. Jovin, and Donna J. Arndt-Jovin, “Magnetic Nanoparticles as Mediators of Ligand-Free Activation of EGFR Signaling,” Plos One, vol. 8, no. 7, 2013. View at Publisher · View at Google Scholar
  • Madhuri Singh, Ravisekhar Gadepalli, Benu Dhawan, and Kasturi Mukhopadhyay, “Combination of Alpha-Melanocyte Stimulating Hormone with Conventional Antibiotics against Methicillin Resistant Staphylococcus aureus,” Plos One, vol. 8, no. 9, 2013. View at Publisher · View at Google Scholar
  • Yan Xu, Lu Tie, Yan Pan, Xuejun Li, Zhenyu Pan, Xin Li, Yefan Wang, Yu An, Shengjun Fan, and Qiang Geng, “Layered Signaling Regulatory Networks Analysis of Gene Expression Involved in Malignant Tumorigenesis of Non-Resolving Ulcerative Colitis via Integration of Cross-Study Microarray Profiles,” Plos One, vol. 8, no. 6, 2013. View at Publisher · View at Google Scholar
  • Fiona Fouhy, Mary O'Connell Motherway, Gerald F. Fitzgerald, R. Paul Ross, Catherine Stanton, Douwe van Sinderen, and Paul D. Cotter, “In Silico Assigned Resistance Genes Confer Bifidobacterium with Partial Resistance to Aminoglycosides but Not to B-Lactams,” Plos One, vol. 8, no. 12, 2013. View at Publisher · View at Google Scholar
  • Lu Jiang, Ting Lan, Yongchang Chen, Jianrong Sang, Yueying Li, Min Wu, Yan Tao, Ying Wang, Hai Qian, and Luo Gu, “PKG II Inhibits EGF/EGFR-Induced Migration of Gastric Cancer Cells,” Plos One, vol. 8, no. 4, 2013. View at Publisher · View at Google Scholar
  • Shuang Li, Ting Hu, Yile Chen, Hang Zhou, Xiong Li, Xiaodong Cheng, Ru Yang, Shixuan Wang, Xing Xie, and Ding Ma, “Adjuvant Chemotherapy, a Valuable Alternative Option in Selected Patients with Cervical Cancer,” Plos One, vol. 8, no. 9, 2013. View at Publisher · View at Google Scholar
  • Lawrence J. Tartaglia, Antonette Bennett, Alexander S. Plattner, Nicholas Muzyczka, Chen Ling, Arun Srivastava, and Mavis Agbandje-McKenna, “Molecular cloning, overexpression, and an efficient one-step purification of alpha 5 beta 1 integrin,” Protein Expression and Purification, vol. 92, no. 1, pp. 21–28, 2013. View at Publisher · View at Google Scholar
  • Min Jueng Kang, Hwang-Phill Kim, Kyeong-seob Lee, Young-Dong Yoo, Yong-Tae Kwon, Kristine M. Kim, Tae-You Kim, and Eugene C. Yi, “Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell-like cells,” Proteomics, vol. 13, no. 10-11, pp. 1714–1725, 2013. View at Publisher · View at Google Scholar
  • Patrizia Ciammella, Maria Paola Ruggieri, Maria Galeandro, Nunziata D'Abbiero, Alessandro Giunta, and Cinzia Iotti, “Short-course preoperative radiotherapy combined with chemotherapy in resectable locally advanced rectal cancer: local control and quality of life,” Radiologia Medica, vol. 118, no. 8, pp. 1397–1411, 2013. View at Publisher · View at Google Scholar
  • Neeraj Lalwani, and Christine O. Menias, “Gestational Trophoblastic Disease,” Radiologic Clinics of North America, vol. 51, no. 6, pp. 1023–+, 2013. View at Publisher · View at Google Scholar
  • Stephanie Hehlgans, Katja Storch, Inga Lange, and Nils Cordes, “The novel HDAC inhibitor NDACI054 sensitizes human cancer cells to radiotherapy,” Radiotherapy and Oncology, vol. 109, no. 1, pp. 126–132, 2013. View at Publisher · View at Google Scholar
  • Alejandro Barrera E, Felipe Illanes F, Guillermo Bannura C, Claudio Vargas N, and Carlos Melo L, “Prognostic value of pathological response to chemo radiotherapy of locally advanced low rectal cancer,” Revista Chilena De Cirugia, vol. 65, no. 3, pp. 236–241, 2013. View at Publisher · View at Google Scholar
  • Alejandro Vazquez-Martin, Silvia Cufi, Cristina Oliveras-Ferraros, Violeta Zenobia Torres-Garcia, Bruna Corominas-Faja, Elisabet Cuyas, Rosa Bonavia, Joana Visa, Begona Martin-Castillo, Enrique Barrajon-Catalan, Vicente Micol, Joaquim Bosch-Barrera, and Javier A. Menendez, “IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations,” Scientific Reports, vol. 3, 2013. View at Publisher · View at Google Scholar
  • Jorge Joven, Begona Martin-Castillo, Enrique Barrajon-Catalan, Joana Visa, Antonio Segura-Carretero, Joaquim Bosch-Barrera, Rosa Bonavia, Bruna Corominas-Faja, Vicente Micol, Alejandro Vazquez-Martin, Elisabet Cuyas, Silvia Cufi, Javier A. Menendez, and Cristina Oliveras-Ferraros, “Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo,” Scientific Reports, vol. 3, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  • Thordur Oskarsson, “Extracellular matrix components in breast cancer progression and metastasis,” The Breast, vol. 22, pp. S66–S72, 2013. View at Publisher · View at Google Scholar
  • Matilde Cescon, and Paolo Bonaldo, “Collagen VI in cancer and its biological mechanisms,” Trends In Molecular Medicine, vol. 19, no. 7, pp. 410–417, 2013. View at Publisher · View at Google Scholar
  • Nobuhiro Ohkohchi, Katsu Hirayama, Ken Saito, Kazuhiro Takahashi, and Shigeki Tsukamoto, “Complete response to multidisciplinary therapy in a patient with primary gastric choriocarcinoma,” World Journal Of Gastroenterology, vol. 19, no. 31, pp. 5187–5194, 2013. View at Publisher · View at Google Scholar
  • Hiromitsu Maehira, Hiromichi Sonoda, Eiji Mekata, Tomoharo Yamaguchi, Tohru Miyake, Mitsuaki Ishida, and Tohru Tani, “A rare case of primary choriocarcinoma in the sigmoid colon,” World Journal of Gastroenterology, vol. 19, no. 39, pp. 6683–6688, 2013. View at Publisher · View at Google Scholar
  • Yanyun Zhu, Junlan Yang, Shunchang Jiao, and Tiefeng Ji, “Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors,” World Journal Of Surgical Oncology, vol. 11, 2013. View at Publisher · View at Google Scholar
  • Alima Gharout-Sait, Abdelaziz Touati, Said Benallaoua, Thomas Guillard, Lucien Brasme, Jannick Madoux, and Christophe De Champs, “CTX-M from community-acquired urinary tract infections in Algeria,” African Journal Of Microbiology Research, vol. 6, no. 25, pp. 5306–5313, 2012. View at Publisher · View at Google Scholar
  • Olga A. Koval, Alexandr S. Fomin, Vasily I. Kaledin, Dmitry V. Semenov, Miraslava O. Potapenko, Elena V. Kuligina, Valery P. Nikolin, Eugeny V. Nikitenko, and Vladimir A. Richter, “A novel pro-apoptotic effector lactaptin inhibits tumor growth in mice models,” Biochimie, vol. 94, no. 12, pp. 2467–2474, 2012. View at Publisher · View at Google Scholar
  • Mohammad Rezaee, Elahe Alizadeh, Darel Hunting, and Léon Sanche, “DNA-Platinum Thin Films for Use in Chemoradiation Therapy Studies,” Bioinorganic Chemistry and Applications, vol. 2012, pp. 1–9, 2012. View at Publisher · View at Google Scholar
  • Bryan Hoang, Raymond M. Reilly, and Christine Allen, “Block Copolymer Micelles Target Auger Electron Radiotherapy to the Nucleus of HER2-Positive Breast Cancer Cells,” Biomacromolecules, vol. 13, no. 2, pp. 455–465, 2012. View at Publisher · View at Google Scholar
  • Bastian Scholz, and Rolf Marschalek, “Epigenetics and blood disorders,” British Journal of Haematology, vol. 158, no. 3, pp. 307–322, 2012. View at Publisher · View at Google Scholar
  • Matthias Kreppel, Sarah Danscheid, Martin Scheer, Jan Christoffer Lüers, Hans Theodor Eich, Joachim E. Zöller, Orlando Guntinas-Lichius, and Dirk Beutner, “Neoadjuvant Chemoradiation in Squamous Cell Carcinoma of the Maxillary Sinus: A 26-Year Experience,” Chemotherapy Research and Practice, vol. 2012, pp. 1–8, 2012. View at Publisher · View at Google Scholar
  • Sophie Martin, Hana Janouskova, and Monique Dontenwill, “Integrins and p53 pathways in glioblastoma resistance to temozolomide.,” Frontiers in oncology, vol. 2, pp. 157, 2012. View at Publisher · View at Google Scholar
  • Rob Glynne-Jones, and Andrew Renehan, “Current Treatment of Anal Squamous Cell Carcinoma,” Hematology-Oncology Clinics of North America, vol. 26, no. 6, pp. 1315–+, 2012. View at Publisher · View at Google Scholar
  • Ezequiel Wexselblatt, Eylon Yavin, and Dan Gibson, “Cellular interactions of platinum drugs,” Inorganica Chimica Acta, vol. 393, pp. 75–83, 2012. View at Publisher · View at Google Scholar
  • Axel Dalhoff, “Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2012, pp. 1–37, 2012. View at Publisher · View at Google Scholar
  • Francis F. Arhin, Ingrid Sarmiento, Thomas R. Parr, and Gregory Moeck, “Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus,” International Journal of Antimicrobial Agents, vol. 39, no. 2, pp. 159–162, 2012. View at Publisher · View at Google Scholar
  • Giada Santin, Luigi Scietti, Paola Veneroni, Sergio Barni, Graziella Bernocchi, and Maria Grazia Bottone, “Effects of Cisplatin in Neuroblastoma Rat Cells: Damage to Cellular Organelles,” International Journal of Cell Biology, vol. 2012, pp. 1–6, 2012. View at Publisher · View at Google Scholar
  • Shih-Chang Tsai, Wen-Wen Huang, Wei-Chien Huang, Chi-Cheng Lu, Jo-Hua Chiang, Shu-Fen Peng, Jing-Gung Chung, Yu-Hsin Lin, Yuan-Man Hsu, Sakae Amagaya, and Jai-Sing Yang, “ERK-modulated intrinsic signaling and G(2)/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells,” International Journal Of Oncology, vol. 41, no. 6, pp. 2065–2072, 2012. View at Publisher · View at Google Scholar
  • Rita Nahta, “Molecular Mechanisms of Trastuzumab-Based Treatment in HER2-Overexpressing Breast Cancer.,” ISRN oncology, vol. 2012, pp. 428062, 2012. View at Publisher · View at Google Scholar
  • Alice Dewdney, and Sheela Rao, “Metastatic Squamous Cell Carcinoma of the Anus: Time for a Shift in the Treatment Paradigm?,” ISRN Oncology, vol. 2012, pp. 1–6, 2012. View at Publisher · View at Google Scholar
  • Pauline Byakika-Kibwika, Mohammed Lamorde, Violet Okaba-Kayom, Harriet Mayanja-Kizza, Elly Katabira, Warunee Hanpithakpong, Nadine Pakker, Thomas P. C. Dorlo, Joel Tarning, Niklas Lindegardh, Peter J. de Vries, David Back, Saye Khoo, and Concepta Merry, “Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults,” Journal Of Antimicrobial Chemotherapy, vol. 67, no. 5, pp. 1217–1223, 2012. View at Publisher · View at Google Scholar
  • D. C. Coraca-Huber, M. Fille, J. Hausdorfer, K. Pfaller, and M. Nogler, “Staphylococcus aureus biofilm formation and antibiotic susceptibility tests on polystyrene and metal surfaces,” Journal Of Applied Microbiology, vol. 112, no. 6, pp. 1235–1243, 2012. View at Publisher · View at Google Scholar